Healthcare / Medical DistributionTokyo
$2053.00
-8.00 (-0.39%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.6B · quality 57.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
53/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$12.2B
P/E
9.9x
↓EV/EBITDA
3.9x
↓ROE
13.2%
↑Gross Margin
11.5%
↓Debt/Equity
0.14
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+5.1%
FCF CAGR
-13.6%
FCF margin
1.4%
FCF / Net income
1.07x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $118.56B · net income $1.50B · FCF $1.61B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $118.56B | $118.56B | $110.47B | $107.96B | $102.07B |
| Net Income | $1.50B | $1.50B | $1.41B | $1.54B | $989.4M |
| EBITDA | $2.83B | $2.83B | $2.68B | $2.56B | $1.94B |
| EPS | 251.68 | 251.68 | 234.90 | 252.80 | 162.66 |
| Gross Margin | 11.5% | 11.5% | 11.7% | 11.6% | 11.4% |
| Operating Margin | 1.9% | 1.9% | 1.9% | 1.9% | 1.5% |
| Net Margin | 1.3% | 1.3% | 1.3% | 1.4% | 1.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.14 | 0.14 | 0.19 | 0.14 | 0.24 |
| Current Ratio | 1.20 | 1.20 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.61B | $1.61B | $-910.5M | $1.97B | $2.49B |
| Returns | |||||
| ROE | 13.2% | 13.2% | 13.7% | 16.9% | 12.2% |
| Valuation | |||||
| P/E | 9.87 | 9.87 | 7.46 | 6.41 | 10.32 |
| EV/EBITDA | 3.91 | 3.91 | 3.75 | 3.10 | 5.17 |
| P/B | 1.07 | 1.07 | 1.02 | 1.08 | 1.26 |
| Growth & Yield | |||||
| Revenue Growth | 7.3% | 7.3% | 2.3% | 5.8% | — |
| EPS Growth | 7.1% | 7.1% | -7.1% | 55.4% | — |
| Dividend Yield | 3.9% | 3.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-10.2%
EPS terminal req.
$182.17
Spread vs growth
17.4%
5Y implied EPS CAGR
-2.6%
EPS terminal req.
$220.43
Spread vs growth
9.8%
10Y implied EPS CAGR
3.5%
EPS terminal req.
$355.00
Spread vs growth
3.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+3.6%
Start / end P/E
8.8x → 8.2x
EPS bridge
234.90 → 251.68
Residual
-0.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.